ASSOCIATION OF ASTHMA CONTROL WITH HEALTH CARE UTILIZATION A PROSPECTIVE EVALUATION
|
|
- Noreen Griffin
- 5 years ago
- Views:
Transcription
1 Online Supplement for: ASSOCIATION OF ASTHMA CONTROL WITH HEALTH CARE UTILIZATION A PROSPECTIVE EVALUATION METHODS Population The Northwest Region of Kaiser Permanente (KPNW) is a large, federally qualified, groupmodel health maintenance organization (HMO) located in Portland, Oregon. KPNW has approximately 450,000 members, whose demographic and socioeconomic characteristics are similar to those of the area population as a whole (E1). The present analysis is based on the results of a survey sent to a subset of KPNW members, aged 18 and older, who had two or more antiasthma medication dispensings in 1996 and/or a hospital or ED visit for asthma in 1994, 1995, or In addition, all individuals had current KPNW health plan coverage as of June 30, A total of 13,964 members met these criteria. We surveyed this population between August and September Everyone received a brief, two-page screening questionnaire (ATAQ, see below). In addition, approximately onequarter also received generic and asthma-specific quality of life questionnaires. Sixty-two percent (8,658) of those we mailed to returned a completed questionnaire, and of these, 60% (5,172) reported that they had a doctor diagnosis of asthma, had taken asthma medications within the past 12 mo, and had answered all the questions relevant for the control index. These constituted the target population for the present analysis. Among these 5,172 individuals, 93% (4,795) had 6 or more mo of KPNW health plan eligibility in the following year, 1998, and thus were included in the analysis. The average duration of health plan eligibility during 1998 for this latter group was 11.8 mo, and 95% had a full 12 mo of eligibility. E1
2 Survey Instrument The Asthma Therapy Assessment Questionnaire (ATAQ) is a brief, self-administered questionnaire designed to assess level of asthma control and identify possible disease management problems. To assess asthma control, the questionnaire asks about: (1) selfperception of asthma control (did you feel that your asthma was well-controlled?); (2) missed work, school, or normal daily activities due to asthma; (3) nighttime waking due to asthma symptoms; and (4) overuse of quick relief inhaler medication, defined here as more than 12 puffs of a reliever medication on any day in the past 4 wk. With the exception of quick reliever use, which involves two questions, each control dimension is assessed using a single question. Respondents are then graded as either having or not having a control problem in each of these dimensions, and the number of control problems is summed to provide an index ranging from 0 to 4. Although the ATAQ instrument assesses these problems relative to both the last year and the last 4 wk, the analysis reported here is based on 4-wk recall responses. Thus, asthma control as reported in this paper reflects short-term asthma control. Copies of the complete ATAQ instrument and detailed coding instructions are available from Merck & Co. Contact Leona Markson at: leona_markson@merck.com. Health Care Utilization The health care utilization data used for this analysis were derived from a number of large administrative and clinical databases maintained by KPNW and briefly summarized below. Although we define acute care as hospitalizations, ED care, and other acute care provided in the regular outpatient clinics, we recognize that some of this is actually convenience care. Similarly, some of what we call routine care may actually be for an acute exacerbation of symptoms. The distinction, nonetheless, has face validity and should generally be accurate. E2
3 Inpatient database. Both KPNW and its alliance hospitals use an automated inpatient scheduling system that serves as the basis for the discharge abstract. We counted as inpatient admissions all hospitalizations occurring in 1998 for which the primary discharge diagnosis was asthma (International Classification of Diseases, Ninth Revision [ICD-9] code = 493.x). Emergency department database. Data for ED care are recorded in a separate database from that used for inpatient care. Primary diagnosis is not entered as an ICD-9 code, but instead is captured in an open text field. We modified a previously developed search string that appears to have good sensitivity and specificity for detecting asthma. Only true ED visits were included in the category of ED care. Some visits to the KPNW urgent care clinic are also captured in this database, but were included in the category other acute care. EpicCare database. EpicCare (EPIC) is KPNW s automated clinical information system. This computerized medical record database includes information on all clinic-based outpatient contacts occurring within KPNW. These contacts are all coded using the ICD-9 classification system, although this classification is done by clinic staff using text strings rather than after the fact by trained nosologists. Thus, for example, a physician will select the diagnosis asthma from a drop-down menu, which is then coded internally as 493. EPIC does not formally distinguish between primary and secondary diagnoses. We therefore considered all contacts with an asthma diagnosis in any of the first 10 diagnosis fields to be asthma utilization. Among the visits so identified, asthma was listed as the first diagnosis 63% of the time. Visits conducted by phone were also counted. Outpatient visits for asthma occurring at the urgency care clinic, as well as other outpatient visits at which a patient received E3
4 nebulizer treatment, were classified as other acute asthma care. All other EPIC contacts were classified as routine care. Claims database. Clinical database (OSCAR) is KPNW s automated claims processing system for recording covered services (generally inpatient and ED care) provided by non-kp facilities. Because any given health care encounter may generate several OSCAR billing records, each with its own primary diagnosis, we classified an encounter as an asthma visit if asthma was listed as the primary diagnosis on any of the 10 largest billings. Outside hospitalizations are also included in the inpatient database; we used OSCAR to capture only outside ED care. Overlapping health care utilization information. We were careful not to overcount encounters. Where such records did exist, we used OSCAR to classify ED care, because OSCAR uses ICD-9 codes versus a text field for the ED database. For other outpatient care, the order of databases from which diagnosis data was taken was EPIC first, inpatient next, and OSCAR last. Outpatient pharmacy database. All medications dispensed at KPNW outpatient pharmacies are recorded in a common database. We used this database to create several summary variables, including (1) total number of antiasthma dispensings (not including prednisone); (2) total number of β-agonist dispensings (inhalers and nebulizers); (3) total number of prednisone dispensings; and (4) the ratio of β -agonist dispensings to inhaled corticosteroid dispensings. Ratios were not calculated for other controller medications, because inhaled corticosteroids were the primary controller therapy used during this time. Although these variables were not used to define any of the health care utilization categories previously described, they were used in some of our prediction equations as noted in the main text. E4
5 Eligibility Data We used KPNW membership records to compute the number of person-months of eligibility for each individual during Person-months were then divided by 12 to get person-years, and this information was used to calculate rates of occurrence of various health care utilization outcomes. Only those individuals with at least 6 mo of eligibility in 1998 were included in the analyses. Statistical Methods Rates of health care utilization are expressed per 1,000 person-years of observation and are computed as the total number of events of interest (e.g., hospitalizations), divided by the total number of person-years of observation, X1,000. For these calculations, total events are counted in the numerator, regardless of whether they represent repeat occurrences for given individuals. Proportions of individuals with different types of health care utilization were computed as the number of individuals with such utilization during 1998 divided by the number of individuals. Reference E1. Freeborn DK, Pope CR. Promise and performance in managed care, 1st edition. Johns Hopkins University Press; Baltimore, MD: 1994, p E5
Asthma Population Management: Identifying Persistent Asthma, Defining High Risk Asthma, and Measuring Quality of Asthma Care
Asthma Population Management: Identifying Persistent Asthma, Defining High Risk Asthma, and Measuring Quality of Asthma Care Michael Schatz, MD, MS Allergy Department Kaiser Permanente, San Diego, CA Constructs
More informationAssociation of Asthma Control with Health Care Utilization and Quality of Life
Association of Asthma Control with Health Care Utilization and Quality of Life WILLIAM M. VOLLMER, LEONA E. MARKSON, ELIZABETH O CONNOR, LESLY L. SANOCKI, LESLYE FITTERMAN, MARC BERGER, and A. SONIA BUIST
More informationUsing an Asthma Control Questionnaire and Administrative Data To Predict Health-Care Utilization*
Original Research ASTHMA Using an Asthma Control Questionnaire and Administrative Data To Predict Health-Care Utilization* Dawn Peters, PhD; Chuhe Chen, PhD; Leona E. Markson, ScD; Felicia C. Allen-Ramey,
More informationType 2 Diabetes: Incremental Medical Care Costs During the 8 Years Preceding Diagnosis. Diabetes Care 23: , 2000
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Type 2 Diabetes: Incremental Medical Care Costs During the 8 Years Preceding Diagnosis GREGORY A. NICHOLS, PHD HARRY S.
More information2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64)
2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Patient Insured - Traditional
More informationAsthma is a common chronic medical condition that is associated
Relationship of Asthma Control to Asthma Exacerbations Using Surrogate Markers Within a Managed Care Database Michael Schatz, MD, MS; Robert S. Zeiger, MD, PhD; Su-Jau T. Yang, PhD; Wansu Chen, MS; William
More informationRapid Effects of Inhaled Corticosteroids in Acute Asthma Gustavo J. Rodrigo, MD.
Rapid Effects of Inhaled Corticosteroids in Acute Asthma Gustavo J. Rodrigo, MD WWW.chestjournal.org Background: Current reviews on the use of inhaled corticosteroids (ICS) for acute asthma underestimated
More informationHospital Discharge Data
Hospital Discharge Data West Virginia Health Care Authority Hospitalization data were obtained from the West Virginia Health Care Authority s (WVHCA) hospital discharge database. Data are submitted by
More informationMeasure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety
Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
More informationModular Program Report
Disclaimer The following report(s) provides findings from an FDA initiated query using Sentinel. While Sentinel queries may be undertaken to assess potential medical product safety risks, they may also
More informationDetroit: The Current Status of the Asthma Burden
Detroit: The Current Status of the Asthma Burden Peter DeGuire, Binxin Cao, Lauren Wisnieski, Doug Strane, Robert Wahl, Sarah Lyon Callo, Erika Garcia, Michigan Department of Health and Human Services
More information2017 HEDIS IET Measure
2017 HEDIS IET Measure Provider Education Webinar Who is MHS Health Wisconsin? MHS Health Wisconsin is one of the State s oldest Medicaid plans, created in 1984, solely to manage the healthcare of the
More informationJuly, Years α : 7.7 / 10, Years α : 11 / 10,000 < 5 Years: 80 / 10, Reduce emergency department visits for asthma.
What are the Healthy People 1 objectives? July, 6 Sponsored by the U.S. Department of Health and Human Services, the Healthy People 1 initiative is a comprehensive set of disease prevention and health
More informationQuality Performance Measurement and Use of Health Information Technology in Critical Access Hospitals
Quality Performance Measurement and Use of Health Information Technology in Critical Access Hospitals Michelle Casey University of Minnesota Rural Health Research Center Flex Monitoring Team 2006 National
More informationReducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital
Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Dawn Waddell, PharmD, BCPS Clinical Pharmacy Manager Lisa Kingdon, PharmD, BCPS Clinical Pharmacy Specialist Dawn Waddell
More informationMeasure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety
Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety 2017 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationPATIENT-IMPACT SCORECARD
UNDERSTANDING THE GSC PATIENT-IMPACT SCORECARD What is the GSC Patient-Impact Scorecard? The GSC Patient-Impact Scorecard shows pharmacy performance scores for GSC patients during the period indicated.
More informationAsthma Among Minnesota Health Care Program Beneficiaries
Asthma Among Minnesota Health Care Program Beneficiaries A JOINT REPORT FROM THE MINNESOTA DEPARTMENT OF HEALTH AND THE MINNESOTA DEPARTMENT OF HUMAN SERVICES November 2018 Asthma Among Minnesota Health
More informationComprehensive Research Plan: Inhaled corticosteroids + long-acting beta agonists (ICS+LABA) for the treatment of asthma
Comprehensive Research Plan: Inhaled corticosteroids + long-acting beta agonists (ICS+LABA) for the treatment of asthma Pharmacoepidemiology Unit July 10, 2014 30 Bond Street, Toronto ON, M5B 1W8 www.odprn.ca
More informationASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp ASTHMA CARE FOR CHILDREN
More informationVIDA SIGNIFICANT ASTHMA EXACERBATION (Visits 2-10, 88 and 90-92)
VIDA SIGNIFICANT ASTHMA EXACERBATION (Visits 2-10, 88 and 90-92) Part. ID: - - Part. Initials: Visit: Visit Date: / / 20 Coordinator ID: (Coordinator Completed) For participants who meet treatment failure
More informationThe Impact of Cardiovascular Disease on Medical Care Costs in Subjects With and Without Type 2 Diabetes
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E The Impact of Cardiovascular Disease on Medical Care Costs in Subjects With and Without Type 2 Diabetes GREGORY A. NICHOLS,
More informationHEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications
HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications Fidelis SecureCare strives to provide quality healthcare to our membership as measured through HEDIS quality metrics.
More informationCost-Motivated Treatment Changes in Commercial Claims:
Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non- Medical Switching August 2017 THE MORAN COMPANY 1 Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non-Medical
More informationCHAPTER 7 SECTION 24.1 PHASE I, PHASE II, AND PHASE III CANCER CLINICAL TRIALS TRICARE POLICY MANUAL M, AUGUST 1, 2002 MEDICINE
MEDICINE CHAPTER 7 SECTION 24.1 ISSUE DATE: AUTHORITY: 32 CFR 199.4(e)(26) I. DESCRIPTION The Department of Defense (DoD) Cancer Prevention and Treatment Clinical Trials Demonstration was conducted from
More informationEpidemiology of First-Episode Psychosis in large, integrated healthcare systems
Epidemiology of First-Episode Psychosis in large, integrated healthcare systems Gregory Simon MD MPH Kaiser Permanente Washington Health Research Institute (formerly Group Health Research Institute) Match
More informationModular Program Report
Modular Program Report Disclaimer The following report(s) provides findings from an FDA initiated query using Sentinel. While Sentinel queries may be undertaken to assess potential medical product safety
More informationOptimising asthma management in high risk patients
C L I N I C A L AU D I T Optimising asthma management in high risk patients Valid to June 2022 bpac nz better medicine Audit focus This audit helps primary care health professionals identify patients with
More informationLOUISIANA MEDICAID PROGRAM ISSUED: 02/01/12 REPLACED: 02/01/94 CHAPTER 5: PROFESSIONAL SERVICES SECTION 5.1: COVERED SERVICES PAGE(S) 6
Diabetes Education Management Training Diabetes self management training (DSMT) is a collaborative process through which recipients with diabetes gain knowledge and skills needed to modify behavior and
More informationPATIENT INFORMATION FORM
PATIENT INFORMATION FORM "I am going to ask you a number of questions about your asthma. The set of questions is somewhat long, but I will try to move through it fairly quickly so that we can complete
More informationThe prevalence and severity of chronic asthma have
An Economic Analysis of Alternative Step-Up Therapies in Asthma Patients Receiving Inhaled Daniel A. Ollendorf, MPH, Alyssa S. Pozniak, BA, Brian W. Bowers, PharmD, Gerry Oster PhD ABSTRACT We analyzed
More informationClinical Quality Measures Summary of Upcoming Enhancements
Upcoming coding enhancements will impact the logic behind the clinical quality indicators applicable to your practice specialty. Please refer to this grid for a summary of the coding enhancements and some
More informationQBPC Claims Based Provider Quick Reference Guide
QBPC Claims Based Provider Quick Reference Guide Category: Diabetes Chronic Suite ICD-10-CM diagnosis HbA1c Test Codes LOINC Evidence of Treatment for Nephropathy Codes E10; E11; E13 83036-37 17856-6,
More informationHUSKY Health Benefits and Prior Authorization Requirements Grid* Behavioral Health Partnership Effective: January 1, 2012
Behavioral Health Health and Behavior Assessments (CPT 96150-96155) When Performed by Psychologists Mental Health Inpatient 100% covered under medical benefit for members with diagnoses outside the range
More informationTrends in Glucocorticoid-Induced Osteoporosis Management Among Seniors in Ontario,
Trends in Glucocorticoid-Induced Osteoporosis Management Among Seniors in Ontario, 1996-2012 Jordan M Albaum 1, Linda E Lévesque 2, Andrea S Gershon 3, Yan Yun Liu 1, Suzanne M Cadarette 1 1 Leslie Dan
More informationSection II: Detailed Measure Specifications
Section II: Detailed Measure Specifications Provide sufficient detail to describe how a measure would be calculated from the recommended data sources, uploading a separate document (+ Upload attachment)
More informationKey Quality of Care Measures. Blue Cross Blue Shield of Michigan Traditional, PPO and POS Members. Fourth Quarter 2003
Key Quality of Care Measures Blue Cross Blue Shield of Michigan Traditional, PPO and POS Members Fourth Quarter 2003 Blue Cross Blue Shield of Michigan is a nonprofit corporation and independent licensee
More informationOptum Research Database Proportion of asthma patients with prescription fills for rescue and controller medications by year,
ASTHMA CHART 1 Optum Research Database Proportion of asthma patients with prescription fills for rescue and controller medications by year, 215-216 7 6 5 4 3 2 1 1 Controller medication 1 Rescue medication
More informationLeeds West CCG Paediatric asthma project. January 2015-January 2017
Leeds West CCG Paediatric asthma project. January 2015-January 2017 Aims to raise asthma awareness improve care reduce emergency attendances and unplanned admissions to secondary care for children with
More informationLong Term Care Formulary RS -29
RESTRICTED USE Asthma/COPD Management 1 of 6 PROTOCOL: Asthma Glossary of Medication Acronyms: SABA: short-acting beta agonist (e.g. salbutamol) SABD: short-acting bronchodilator (e.g. ipratropium or SABA)
More informationCOSTS OF DIABETES IN DEVELOPING COUNTRIES
COSTS OF DIABETES IN DEVELOPING COUNTRIES Jonathan Betz Brown, MPP, PhD Chair, International Diabetes Federation Task Force on Diabetes Health Economics Senior Investigator, Kaiser Permanente Center for
More informationBlue Cross and Blue Shield of New Mexico and Lovelace Health Plan Transactions Frequently Asked Questions
Blue Cross and Blue Shield of New Mexico and Lovelace Health Plan Transactions Frequently Asked Questions Blue Cross and Blue Shield of New Mexico (BCBSNM), has received regulatory approval to acquire
More informationand will be denied as not medically necessary** if not met. This criterion only applies to the initial
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationPolicy Evaluation: Step Therapy Prior Authorization of Combination Inhaled Corticosteroid / Long-Acting Beta-Agonists
Drug Use Research & Management Program OHA Division of Medical Assistance Programs 500 Summer Street NE, E35; Salem, OR 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Policy Evaluation: Step Therapy Prior
More informationValue of Hospice Benefit to Medicaid Programs
One Pennsylvania Plaza, 38 th Floor New York, NY 10119 Tel 212-279-7166 Fax 212-629-5657 www.milliman.com Value of Hospice Benefit May 2, 2003 Milliman USA, Inc. New York, NY Kate Fitch, RN, MEd, MA Bruce
More informationStudy Exposures, Outcomes:
GSK Medicine: Coreg IR, Coreg CR, and InnoPran Study No.: WWE111944/WEUSRTP3149 Title: A nested case-control study of the association between Coreg IR and Coreg CR and hypersensitivity reactions: anaphylactic
More informationPredicting, Preventing and Managing Asthma Exacerbations. Heather Zar Department of Paediatrics & Child Health University of Cape Town South Africa
Predicting, Preventing and Managing Asthma Exacerbations Heather Zar Department of Paediatrics & Child Health University of Cape Town South Africa Asthma exacerbations Predicting exacerbation recognising
More informationNCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits
NCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits Overall Goal: To identify strategies for providing comprehensive care during a well visit. The provision of comprehensive
More information«Impact of a pharmaceutical intervention to improve adherence of inhaled medication in asthma and COPD patients»
«Impact of a pharmaceutical intervention to improve adherence of inhaled medication in asthma and COPD patients» Baseline data from a randomized controlled trial 5 th Swiss Health Services Research Symposium,
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Mortality Measures Set
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set
More informationChapter 18 Section 2. EXPIRED - Department Of Defense (DoD) Cancer Prevention And Treatment Clinical Trials Demonstration
s And Pilot Projects Chapter 18 Section 2 EXPIRED - Department Of Defense (DoD) Cancer Prevention And Treatment Clinical Trials 1.0 PURPOSE The purpose of this demonstration is to improve TRICARE-eligible
More informationPeak Expiratory Flow Rate (PEFR) for ED Management of Acute Asthma Exacerbation
Peak Expiratory Flow Rate (PEFR) for ED Management of Acute Asthma Exacerbation PI: Brian Driver, MD Checklist Reviewed Inclusion and Exclusion Criteria Confirm pertinent exclusion criteria with PMP Engage
More informationAsthma: Evaluate and Improve Your Practice
Potential Barriers and Suggested Ideas for Change Key Activity: Initial assessment and management Rationale: The history and physical examination obtained from the patient and family interviews form the
More informationCardiovascular Health and Diabetes Screening for People with Schizophrenia
Cardiovascular Health and Diabetes Screening for People with Schizophrenia The percentage of members 25 years and older with a schizophrenia diagnosis and who were prescribed any antipsychotic medication,
More informationHEDIS. Quick Reference Guide. For more information, visit
HEDIS Quick Reference Guide For more information, visit www.ncqa.org HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2018 Technical Specifications Michigan Complete Health strives to provide
More information2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2012 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2012 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More informationBuilding a learning healthcare system for suicide prevention
Building a learning healthcare system for suicide prevention Gregory Simon MD MPH Kaiser Permanente Washington Health Research Institute Mental Health Research Network Depression and Bipolar Support Alliance
More informationAnesthesia Reimbursement
This drafted policy is open for a two-week public comment period. This box is not part of the drafted policy language itself, and is intended for use only during the comment period as a means to provide
More information2017 Blue Cross and Blue Shield of Louisiana
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationDisease Management. Measures At A Glance
s At A Glance Updated: 11/01/2018 URAC 2018 Page 1 of 7 Cross-Cutting Mandatory s (3) Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on
More informationOptimal Asthma Control Data Specifications
Optimal Asthma Control Data Specifications Final Version December 2009: Updated for Population Identification April 2010 MNCM Measure Description Methodology Rationale Composite measure of the percentage
More informationAdjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 16 Years and Older
Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 16 Years and Older The Canadian Thoracic Society and other international asthma
More informationDisclosure. Case. Objectives. Case Continued. Inhalers. Asthma: A GINA Update to the NAEPP 2007 Guidelines 1/20/2015
Disclosure Asthma: A GINA Update to the NAEPP 2007 Guidelines Robert (RC) Hellinga, Pharm.D. PGY 1 Pharmacy Resident Wolfson Children s Hospital/Baptist Health I do not have a vested interest in or affiliation
More informationArkansas Health Care Payment Improvement Initiative Congestive Heart Failure Algorithm Summary
Arkansas Health Care Payment Improvement Initiative Congestive Heart Failure Algorithm Summary Congestive Heart Failure Algorithm Summary v1.2 (1/5) Triggers PAP assignment Exclusions Episode time window
More informationشءءذص Primary Care Respiratory. Tools to help you stratify people with asthma who should be offered a priority review
م م مء مكى مس Tools to help you stratify people with asthma who should be offered a priority review explores how to help stratify people with asthma providing م ف م خ links to XML files you can access
More informationHEDIS. Quick Reference Guide. For more information, visit
HEDIS Quick Reference Guide For more information, visit www.ncqa.org HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2017 Technical Specifications Michigan Complete Health Medicare-Medicaid Plan
More informationLearning Objectives. Guidance Hierarchy. AHA Coding Clinic Update
1 AHA Coding Clinic Update Nelly Leon Chisen, RHIA Director, Coding and Classification Executive Editor, Coding Clinic American Hospital Association Chicago, IL Learning Objectives At the completion of
More informationTitle of Project: NHS Dumfries & Galloway Respiratory Bundle Asthma: Bronchodilator Overuse Review April 2015
Title of Project: NHS Dumfries & Galloway Respiratory Bundle Asthma: Bronchodilator Overuse Review April 2015 1 Reason for the review Respiratory prescribing is long term and can be costly. Appropriate
More informationDeveloped By Name Signature Date
Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:
More informationOutpatient Therapy Services
Payment Policy: Outpatient Therapy Services Purpose: Commonwealth Care Alliance (CCA) reimburses contracted providers for medically necessary covered outpatient therapy s. Therapy s may include physical
More informationThe National Asthma Education and Prevention Program s
Long-Acting b-agonist Among Children and Adults With Asthma Elizabeth A. Wasilevich, PhD, MPH; Sarah J. Clark, MPH; Lisa M. Cohn, MS; and Kevin J. Dombkowski, DrPH Managed Care & Healthcare Communications,
More informationCounseling to Prevent Tobacco Use
News Flash Vaccination is the Best Protection Against the Flu. This year, the Centers for Disease Control and Prevention (CDC) is encouraging everyone 6 months of age and older to get vaccinated against
More informationUnitedHealth Premium Designation Program Case-mix Adjusted Benchmarks with Severity or Risk Adjustment
UnitedHealth Premium Designation Program Case-mix Adjusted Benchmarks with Severity or Risk Adjustment Resources u Phone: 866-270-5588 u u u Website: UnitedHealthcareOnline.com > Quick Links > UnitedHealth
More informationMULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient
Clinical Guideline Ver. 2.0 MULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient Target Audience: The target audience for this clinical guideline is all MHS providers
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #52 (NQF 0102): Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Fasenra) Reference Number: CP.PHAR.## Effective Date: 01.16.18 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy
More informationPerformance Improvement Projects Related to CDC s 6 18 Initiative: A Scan of External Quality Review Organization Reports
Technical Assistance Tool June 2018 Performance Improvement Projects Related to CDC s 6 18 Initiative: A Scan of External Quality Review Organization Reports S tates implementing interventions under CDC
More informationAsthma Coding Fact Sheet for Primary Care Pediatricians
01/01/2017 Asthma Coding Fact Sheet for Primary Care Pediatricians Physician Evaluation & Management Services Outpatient 99201 99202 99203 99204 99205 Office or other outpatient visit, new patient; self
More informationIdentifying Adult Mental Disorders with Existing Data Sources
Identifying Adult Mental Disorders with Existing Data Sources Mark Olfson, M.D., M.P.H. New York State Psychiatric Institute Columbia University New York, New York Everything that can be counted does not
More informationKaiser Permanente s Experience in Coverage and Conduct of Oncology Clinical Trials
Kaiser Permanente s Experience in Coverage and Conduct of Oncology Clinical Trials IOM/ASCO Implementation Planning Workshop Sharon Levine MD Associate Executive Director, Kaiser Permanente March 21, 2011
More informationFY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine
FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine
More informationIssue Brief. Eliminating Adult Dental Benefits in Medi-Cal: An Analysis of Impact. Introduction. Background
Eliminating Adult Dental Benefits in Medi-Cal: An Analysis of Impact Introduction In 2009, California eliminated non-emergency dental services for adults in its Medicaid program, Medi-Cal. The California
More informationSYNOPSIS A two-stage randomized, open-label, parallel group, phase III, multicenter, 7-month study to assess the efficacy and safety of SYMBICORT
Drug product: Drug substance(s): Edition No.: Study code: SYMBICORT pmdi 160/4.5 g Budesonide/formoterol D5896C00005 Date: 8 May 2006 SYNOPSIS A two-stage randomized, open-label, parallel group, phase
More informationClinical Policy: Fluticasone/Salmeterol (Advair Diskus, Advair HFA) Reference Number: CP.PMN.31 Effective Date: 08/16 Last Review Date: 08/17
Clinical Policy: (Advair Diskus, Advair HFA) Reference Number: CP.PMN.31 Effective Date: 08/16 Last Review Date: 08/17 Line of Business: Medicaid Revision Log See Important Reminder at the end of this
More informationHospice Metrics Using Medicare Data to Measure Access and Performance for Hospice and Palliative Care
Hospice Metrics Using Medicare Data to Measure Access and Performance for Hospice and Palliative Care 1 Outline What are the Medicare data? What are the important metrics? Why hospitals matter so much
More information2017 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2017 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2017 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More informationHealthy People 2010 Asthma Objectives December 2009 Update
December 2009 Update Healthy People 2010 is a set of national health goals focusing on disease prevention and health promotion to be reached by the year 2010. The following are the Healthy People 2010
More informationKey Findings and Recommendations from the
June 2014 Improving Community Health Through Policy Research Key Findings and Recommendations from the 2013 IPLA INSPECT Knowledge and Use Survey 2014 Center for Health Policy (14-H54) IU Richard M Fairbanks
More informationValidating a computable phenotype: Should results change a trial s primary outcome?
Validating a computable phenotype: Should results change a trial s primary outcome? Gregory Simon MD MPH Susan Shortreed PhD Kaiser Permanente Washington Health Research Institute Supported by NIMH Cooperative
More informationGSK Clinical Study Register
In February 2013, GlaxoSmithKline (GSK) announced a commitment to further clinical transparency through the public disclosure of GSK Clinical Study Reports (CSRs) on the GSK Clinical Study Register. The
More informationDepression and Anxiety Relative Risks in Women Newly Diagnosed with Vulvovaginal Atrophy and Dyspareunia
Depression and Anxiety Relative Risks in Women Newly Diagnosed with Vulvovaginal Atrophy and Dyspareunia Moyneur, Erick MA 1, Dea, Katherine MSc 1, Derogatis, Len PhD 2, Labrie, Fernand MD, PhD 3 1 StatLog
More information2013 Chronic Respiratory. Program Description. Our mission is to improve the health and quality of life of our members
2013 Chronic Respiratory Program Description Our mission is to improve the health and quality of life of our members Chronic Respiratory Program Description I. Purpose Care Coordination promotes the Plan
More informationPharmacy Medical Policy IgE Receptor Binding Inhibitors
Pharmacy Medical Policy IgE Receptor Binding Inhibitors Table of Contents Policy: Commercial Policy History Endnotes Policy: Medicare Information Pertaining to All Policies Forms Coding Information References
More informationClaim Submission. Agenda 1/31/2013. Payment Basics
February 2013 Jean C. Russell, MS, RHIT jrussell@epochhealth.com Richard Cooley, BA, CCS rcooley@epochhealth.com 518-430-1144 2 Payment Basics Agenda 2013 PT / OT / SP Codes Deleted Codes New Codes Significant
More informationSUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES
Summary Table of Measures, Product Lines and Changes 1 SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES General Guidelines for Data Collection and Reporting Guidelines for Calculations and Sampling
More informationImproving asthma outcomes in large populations
Current perspectives Improving asthma outcomes in large populations Michael Schatz, MD, MS, and Robert S. Zeiger, MD, PhD San Diego, Calif This article summarizes our experience using administrative, survey,
More information#1 cause of school absenteeism in children 13 million missed days annually
Asthma Update 2013 Jennifer W. McCallister, MD, FACP, FCCP Associate Professor Pulmonary & Critical Care Medicine The Ohio State University Wexner Medical Center Disclosures None 2 Objectives Review burden
More informationZhao Y Y et al. Ann Intern Med 2012;156:
Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled
More informationApproved Care Model for Project 3dii: Expansion of the Home Environmental Asthma Management Program
1 Approved Care Model for Project 3dii: Expansion of the Home Environmental Asthma Management Program OneCity Health Webinar January 6, 2016 Overview of presentation 2 Approach to care model development
More information